Seed
Stage at our first check
2021
Year we invested
Boston
Headquarters
48 people
Team today
What they do
Founded by Hannah Reiss and Marcus Cole.
Verdant builds the software and robotics that let a small biology team run experiments at a scale that used to require a much larger lab. Protocols are versioned, runs are reproducible, and results come back structured.
Their customers are companies of five to fifty people who need throughput long before they can afford to build their own automation group.
Why we invested
This was our first investment outside software, and we spent longer on it than usual. What convinced us was watching two customers describe Verdant as the reason they could stay small, which is a durable kind of dependency.
Kenji Watanabe, Partner
Timeline
How it has gone so far.
Seed round led by us.
Series A after signing eleven biotech customers.
Second facility opens outside Boston.
More of the portfolio
Companies we backed at the same stage.
Elsewhere in the portfolio.
Next step
Building something like Verdant?
We write first checks at pre-seed and seed, and we answer within two business days.